Home/Filings/4/0001209191-14-072889
4//SEC Filing

Cara Therapeutics, Inc. 4

Accession 0001209191-14-072889

$TVRDCIK 0001346830operating

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 7:23 PM ET

Size

7.1 KB

Accession

0001209191-14-072889

Insider Transaction Report

Form 4
Period: 2014-12-01
Stauffer Joseph William
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2014-12-01+180,000180,000 total
    Exercise: $8.74Exp: 2024-12-01Common Stock (180,000 underlying)
  • Award

    Common Stock

    2014-12-01$8.74/sh+11,442$100,00311,442 total
Footnotes (1)
  • [F1]One-fourth (1/4th) of the shares shall vest and become exercisable on December 1, 2015; the balance of the shares shall vest and become exercisable in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service with the issuer as of each such date.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001346830

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 7:23 PM ET
Size
7.1 KB